1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Atreca, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies ATRC-101, Pembrolizumab, Pegylated liposomal doxorubicin (PLD) - Breast Cancer, Colorectal Cancer | Phase 1 | Terminated | Atreca, Inc. | 87 | 2020-02-11 | 2023-12-29 |
Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Transitional Cell (1) · Colorectal Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Melanoma (1) · Ovarian Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Triple Negative Breast Neoplasms (1)
1-dodecylpyridoxal (1) · liposomal doxorubicin (1) · pembrolizumab (1)
United States (1)